Managing the pharmacy benefit in Medicare HMOs: what do we really know?

H L Lipton, D J Gross, M R Stebbins, and L H Syed

An estimated five million Medicare beneficiaries received outpatient prescription drug benefits through Medicare + Choice in 1999. However, little is known about how these benefits are managed or about their effects on costs and quality of care. This exploratory study applies a case-study methodology to four large Medicare health maintenance organizations (HMOs) to identify and assess drug-use management strategies. It also poses a number of important issues for consideration by both policymakers and health services researchers, as the debate rages on over the creation and administration of a Medicare outpatient drug benefit, especially in light of the predilection for the use of private pharmacy benefit managers (PBMs) in many of these proposals.

What's this?

Home

Current Issue

Journal Article

Managing the pharmacy benefit in Medicare HMOs: what do we really know?